SAREPTA THERAPEUTICS, INC. Loss Contingency, Damages Sought, Value
SAREPTA THERAPEUTICS, INC. (SRPT) reported Loss Contingency, Damages Sought, Value of $4.00 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-08.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyDamagesSoughtValue · last filed 2014-05-08
- SAREPTA THERAPEUTICS, INC. loss contingency, damages sought, value for the quarter ending 2014-03-31 was $4.00M.
- SAREPTA THERAPEUTICS, INC. loss contingency, damages sought, value for fiscal 2013 was $4.00M.
| Period end | Loss Contingency, Damages Sought, Value 3 month | Loss Contingency, Damages Sought, Value 12 month |
|---|---|---|
| 2014-03-31 | $4.00M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $4.00M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |